psychedelic drug derivative psychedelic phenethylamine appeared online vendor sites reported literature acts potent agonist studied radiolabelled form potential ligand mapping distribution receptors brain using positron emission tomography multiple deaths occurred usage due ease accidental overdose longterm toxic effects drug researched derived psychedelic phenethylamine substitution amine group clumpy white powder notably bitter metallic taste found blotter mimics sold extremely potent effects drug increase greatly within small window dosage adjustment overdose may occur little double average dose inaccurate dosing street blotter paper mistaken lsd taken powder liquid resulted multiple accidental one study shown blotters hotspots drug dosage evenly applied surface paper could lead sublingually threshold onset hallucinogenic effects reportedly Î¼g mild effects strong effects strong effects nbomesubstituted compounds diminished absorption rate passing mucus membranes generally remain inactive taken orally buccal sublingual insufflated routes administration viable options absorption rate buccally sublingually increased complexed hpbcd complexing sugar however efficient nasal administration shortens duration increasing intensity attributed several overdoses includes negative side effects arising overdose likelihood negative side effects increases dose nbome compounds often associated lifethreatening toxicity studies nbome family compounds demonstrated substance exhibit neurotoxic cardiotoxic reports autonomic dysfunction remains prevalent nbome compounds individuals experiencing sympathomimetic toxicity vasoconstriction hypertension tachycardia addition symptoms toxidrome include agitation aggression seizure hyperthermia diaphoresis hypertonia rhabdomyolysis researchers report nbome intoxication frequently display signs serotonin likelihood seizure higher nbomes compared nbome nbohs regularly sold lsd blotter bitter taste different safety despite high potency recreational doses lsd produced low incidents acute fatalities involved nbome intoxication suggest significant number individuals ingested substance believed researchers report users familiar lsd may false sense security ingesting nbome fatalities due physical effects drug also reports death due selfharm suicide influence many nbome compounds high potency agonist activity additional receptors prolonged activation cause cardiac valvulopathy high doses chronic receptors strongly implicated causing druginduced valvular heart high affinity nbome compounds adrenergic receptor reported contribute stimulanttype cardiovascular vitro studies shown exhibit cytotoxicity neuronal cell lines compound potent methamphetamine reducing visibility respective cells neurotoxicity compound involves activation mapkerk cascade inhibition aktpkb signaling including derivative reduced visibility cardiomyocytes cells substances downregulated expression level kinase enzyme documented cardiac protective october controlled substance schedule iii nbome series psychoactives became controlled israel may sold designer drug new zealand early withdrawn sale statement associate health minister peter dunne would considered substantially similar chemical structure illegal hallucinogen dob therefore class c controlled drug russia became first country regulate nbome class entire nbome series psychoactives became controlled russian federation starting october sveriges riksdag added schedule substances plant materials fungi normally medical use narcotics sweden aug published medical products agency regulation lvfs listed substance class drug united kingdom result nbenzylphenethylamine catchall clause misuse drugs act several nbome series compounds temporarily scheduled united states years temporary scheduling applies november temporary scheduling extended another october controlled substance banned czech analogues derivatives stimulants phenylethanolamine